229 related articles for article (PubMed ID: 16195238)
1. Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5.
Hussain-Hakimjee EA; Peng X; Mehta RR; Mehta RG
Carcinogenesis; 2006 Mar; 27(3):551-9. PubMed ID: 16195238
[TBL] [Abstract][Full Text] [Related]
2. Regulation of steroid receptor expression by 1alpha-hydroxyvitamin D5 in hormone-responsive breast cancer cells.
Hussain-Hakimjee EA; Mehta RG
Anticancer Res; 2009 Sep; 29(9):3555-61. PubMed ID: 19667148
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy.
Hussain EA; Mehta RR; Ray R; Das Gupta TK; Mehta RG
Recent Results Cancer Res; 2003; 164():393-411. PubMed ID: 12899538
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.
Mehta RG; Hussain EA; Mehta RR; Das Gupta TK
Mutat Res; 2003; 523-524():253-64. PubMed ID: 12628523
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxyvitamin D5.
Mehta RG
Eur J Cancer; 2004 Oct; 40(15):2331-7. PubMed ID: 15454260
[TBL] [Abstract][Full Text] [Related]
7. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
8. Identification of VDR-responsive gene signatures in breast cancer cells.
Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
10. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
11. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
[TBL] [Abstract][Full Text] [Related]
12. 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines.
Koike M; Elstner E; Campbell MJ; Asou H; Uskokovic M; Tsuruoka N; Koeffler HP
Cancer Res; 1997 Oct; 57(20):4545-50. PubMed ID: 9377567
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
14. Expression and regulation by serum of multiple FGF1 mRNA in normal transformed, and malignant human mammary epithelial cells.
Renaud F; El Yazidi I; Boilly-Marer Y; Courtois Y; Laurent M
Biochem Biophys Res Commun; 1996 Feb; 219(3):679-85. PubMed ID: 8645241
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
16. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors.
Wagner CR; Ballato G; Akanni AO; McIntee EJ; Larson RS; Chang S; Abul-Hajj YJ
Cancer Res; 1997 Jun; 57(12):2341-5. PubMed ID: 9192804
[TBL] [Abstract][Full Text] [Related]
19. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
Perera CN; Chin HG; Duru N; Camarillo IG
J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites.
Fernandez SV; Russo IH; Lareef M; Balsara B; Russo J
Int J Oncol; 2005 Mar; 26(3):691-5. PubMed ID: 15703825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]